Concepedia

Juha Kaivola

JK

4

Publications

413

Citations

4

H-Index

1993

Active since

Affiliations

Orion Corporation (Finland)(Current)

Juha Kaivola is an author at Orion Corporation (Finland) specializing in medicine, pharmacology, and biochemistry.

Top concepts

MedicinePharmacologyBiochemistryNeuropharmacologySignal TransductionMolecular PhysiologyPhysiologyDrug DiscoveryNeuroprotectionPharmacotherapy

Publications per year

1993–2000

4

Publications

4

Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study.

Piero Pollesello, Martti Ovaska, Juha Kaivola et al. · Journal of Biological Chemistry · 1994 · 233 citations · Full text

Levosimendan Binds, Molecular Pharmacology, Cardiac Muscle +14

Further Evidence for the Cardiac Troponin C Mediated Calcium Sensitization by Levosimendan: Structure-response and Binding Analysis with Analogs of Levosimendan

Jouko Levijoki, Piero Pollesello, Juha Kaivola et al. · Journal of Molecular and Cellular Cardiology · 2000 · 81 citations

Signal Transduction, Molecular Physiology, Biochemistry +5

Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production

Erkki Nissinen, Petri Kaheinen, Kai E. Penttilä et al. · European Journal of Pharmacology · 1997 · 69 citations

Novel Catechol-o-methyltransferase Inhibitor, Mitochondrial Function, Biochemistry +6

Postnatal development of diazepam-insensitive [3H]RO 15-4513 binding sites

Esa R. Korpi, Mikko Uusi‐Oukari, Juha Kaivola · Neuroscience · 1993 · 30 citations

Functional Selectivity, Medicine, Mechanism Of Action +4

Rows per page

1–4 of 4